The Evolut™ PRO System combines exceptional valve design and advanced sealing with an excellent safety profile.
The optimal oversizing feature of the self-expanding frame provides a consistent radial force against the annulus helping to maintain a larger EOA.
Supra-annular valve design maximizes leaflet coaptation and promotes single digit gradients and large EOAs.
Evolut Pro Clinical Study, 60 patients, 30-day outcomes
1:1 response provides immediate feedback between the deployment knob and the movement of the capsule.
The only TAVR system with a vessel indication down to 5.0 mm‡
The EnVeo R delivery system in-line sheath retains its outer diameter as it enters the vessel and remains at this diameter as it is advanced to the annulus.
The only TAVR platform indicated to treat annulus up to 30 mm.
EnVeo™ R provides an option to recapture and reposition to assist with accurate placement.§
Transcatheter Aortic Valve in Failed Surgical Bioprosthesis
A large implant window and recapturability with the Evolut TAVR Platform enable positive outcomes for VIV procedures.
Broadest annulus range based on CT derived diameters
Measurement for TAV in SAV only.
Evolut R 23, 26 and 29 mm valves. Evolut PRO 23, 26, 29 mm valves and Evolut R 34 mm valve minimum vessel indication ≥ 5.5 mm.
Per Instructions for Use: If the bioprosthesis has been recaptured 3 times, withdraw the recaptured bioprosthesis.
Up to 80% deployment